Rx Safety Triggers Tighten As Senate Continues Work On FDA Revitalization Act

Provisions that specify which information will trigger the requirement for a drug to have a Risk Evaluation and Mitigation Strategy have been added to the FDA Revitalization Act as Senate floor debate on the bill continues